BRIEF published on 12/19/2025 at 12:05, 6 months 3 days ago Biotest AG annonce l'approbation par la FDA du Fesilty™ de Grifols Biotest AG Marché Américain Approbation De La FDA Grifols Thérapie Au Fibrinogène
BRIEF published on 12/19/2025 at 12:05, 6 months 3 days ago Biotest AG Announces FDA Approval of Grifols' Fesilty™ FDA Approval Biotest AG U.S. Market Grifols Fibrinogen Therapy
PRESS RELEASE published on 12/19/2025 at 12:00, 6 months 3 days ago Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) Biotest AG announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) for acute bleeding episodes in patients with fibrinogen deficiency Biotest AG Fibrinogen Grifols US FDA Approval Fesilty
BRIEF published on 11/13/2025 at 10:12, 7 months 9 days ago Biotest obtient l'autorisation de mise sur le marché de Prufibry® en Allemagne Biotest AG Essais Cliniques Marché Allemand Approbation Prufibry® Déficit En Fibrinogène
BRIEF published on 11/13/2025 at 10:12, 7 months 9 days ago Biotest Obtains Approval for Prufibry® in Germany Clinical Trials Biotest AG German Market Prufibry® Approval Fibrinogen Deficiency
PRESS RELEASE published on 11/13/2025 at 10:07, 7 months 9 days ago Biotest obtains approval for new human fibrinogen Prufibry® in Germany Biotest AG obtains approval in Germany for new human fibrinogen Prufibry®, expanding intensive care and coagulation factor portfolio with a life-saving therapy for congenital and acquired fibrinogen deficiency Germany Biotest AG Approval Human Fibrinogen Prufibry
BRIEF published on 11/07/2025 at 15:24, 7 months 15 days ago Biotest AG convoque une assemblée générale extraordinaire à la demande de Grifols Assemblée Générale Extraordinaire Grifols SA Société En Commandite Par Actions Biotest AG Changement De Forme Juridique
BRIEF published on 11/07/2025 at 15:24, 7 months 15 days ago Biotest AG Schedules Extraordinary General Meeting at Grifols' Request Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
PRESS RELEASE published on 11/07/2025 at 15:19, 7 months 15 days ago Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A. Biotest AG convenes an extraordinary general meeting at the request of Grifols S.A. to discuss changing its legal form to a partnership limited by shares (KGaA) on 17 December 2025 Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
BRIEF published on 10/23/2025 at 13:21, 7 months 30 days ago Biotest AG Cancels Extraordinary General Meeting Grifols S.A. Extraordinary General Meeting Legal Form Change Corporate Restructuring Biotest AG News
Published on 06/22/2026 at 21:05, 1 hour 15 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 2 hours 35 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 6 hours 22 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 6 hours 50 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 7 hours 20 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 21:07, 1 hour 13 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 1 hour 30 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 1 hour 48 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 2 hours 53 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:54, 3 hours 26 minutes ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:00, 4 hours 20 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION
